BioNTech (NASDAQ:BNTX) shares fell Friday after the company said it had been informed by partner OncoC4 that FDA placed ...
A new drug combo recently approved by the Food & Drug Administration can halt lung cancer in its treacherous tracks — for ...
The FDA has implemented a partial hold on a phase 3 non-small cell lung cancer trial run by BioNTech and OncoC4 after seeing ...
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...
What’s more, AM-101 improved radiation treatment, slowing down the growth of NSCLC subcutaneous xenograft tumors in mice, by ...
When you think of lung cancer treatment, what comes to mind—chemotherapy, radiation, surgery? While these can be crucial, ...
4d
Research shows regular physical activity can significantly improve quality of life for lung cancer patients. This includes ...
At the moment, there’s just not enough data to understand what’s happened to the tens of thousands of missing cancer cases, ...
Novocure received a long-sought FDA approval for the use of its Tumor Treating Fields technology against metastatic non-small ...
There are no approved therapies to tackle c-Met protein overexpression, AbbVie said in a press release. C-Met is a receptor ...
Aspirin did not impact CVD incidence; however, risk may be higher in those with metastatic, hematological and lung cancer and ...
The move is a blow to Gilead’s cancer portfolio. Trodelvy, an antibody-drug conjugate granted accelerated approval for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback